
Sign up to save your podcasts
Or


Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
CME information and select publications here.
By Dr. Neil Love4.4
7272 ratings
Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
CME information and select publications here.

322 Listeners

40 Listeners

66 Listeners

31 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

121 Listeners

59 Listeners

1,145 Listeners

47 Listeners

2 Listeners

365 Listeners

54 Listeners

62 Listeners

51 Listeners

197 Listeners

46 Listeners

30 Listeners

0 Listeners